admin

Check out the companies making headlines before the bell: Moderna (MRNA) – Moderna shares fell 2.4% in the premarket, despite reporting better-than-expected earnings and revenue and saying its Covid-19 vaccine is 93% effective after 6 months. Moderna earned $6.46 per share for its latest quarter, beating the $5.96 consensus estimate. Cigna (CI) – The insurance
0 Comments
Download Preston’s 1 page checklist for finding great stock picks: http://buffettsbooks.com/checklist Preston Pysh is the #1 selling Amazon author of two books on Warren Buffett. The books can be found at the following location: http://www.amazon.com/gp/product/1939370159/ref=as_li_tl?ie=UTF8&camp=1789&creative=9325&creativeASIN=1939370159&linkCode=as2&tag=pypull-20&linkId=XRE5CA2QJ3I2OWSW
0 Comments
In this episode of hungry for returns, we are going to talk about at the money, in the money and out of the money when it comes to trading options, and which is the best for day trading options without leaving any positions open overnight. #daytrading #tradingoptions #moneyoptions #optionstraining #tradingclass Posted at: https://tradersfly.com/blog/day-trading-options-hfr-3/ ? GET
0 Comments
Compass Pathways (NASDAQ:CMPS) has been beaten up lately. But the fundamentals are rapidly improving, making now a great time to buy this psychedelic stock. Source: Shutterstock CMPS and other companies championing psychedelic-based therapies are seeing legalization tailwinds grow rapidly. Many cities across the U.S. are in talks to decriminalize psilocybin, among other substances. Cities in
0 Comments
By-and-large, meme stocks have moved lower last month. But Exela Technologies (NASDAQ:XELA) stock was one that bucked the trend. Source: shutterstock.com/Luca Lorenzelli Shares in the business process automation provider are no stranger to rallies fueled by Reddit’s r/WallStreetBets community. Before its short-lived July run-up, it experienced a similar brief period of off-the-charts enthusiasm back in
0 Comments
This may seem like a weird time to be recommending Exxon Mobil (NYSE:XOM) stock. Inflation expectations — and policymakers’ lack of clarity regarding plans to curb any potential inflation crisis — are discouraging investors. None of us can control the fact that central authorities are prioritizing per-capita GDP recovery while ignoring surging prices. Source: Jonathan
0 Comments